Tiboloni (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tiboloni" in Finnish language version.

refsWebsite

Global rank Finnish rank

15nih.gov

4^th place

12^th place

12doi.org

2^nd place

10^th place

7books.google.com

3^rd place

75^th place

5semanticscholar.org

11^th place

2,329^th place

1springer.com

274^th place

418^th place

1duodecimlehti.fi

low place

109^th place

1inserm.fr

9,568^th place

low place

1drugs.com

399^th place

2,670^th place

1archive.org

6^th place

164^th place

archive.org (Global: 6^th place; Finnish: 164^th place)

Hormone Use in Menopause and Male Andropause : A Choice for Women and Men: A Choice for Women and Men, s. 73–. Oxford University Press, USA, 4 October 2003. ISBN 978-0-19-803620-3 Teoksen verkkoversio.

books.google.com (Global: 3^rd place; Finnish: 75^th place)

Ganellin CR, Triggle DJ: Dictionary of Pharmacological Agents, s. 1974–. CRC Press, 21 November 1996. ISBN 978-0-412-46630-4 Teoksen verkkoversio.
Morton IK, Hall JM: Concise Dictionary of Pharmacological Agents: Properties and Synonyms, s. 275–. Springer Science & Business Media, 6 December 2012. ISBN 978-94-011-4439-1 Teoksen verkkoversio.
Menopause: A Comprehensive Approach, s. 103–. Springer, 2 November 2017. ISBN 978-3-319-59318-0 Teoksen verkkoversio.
Clinical Reproductive Medicine and Surgery: A Practical Guide, s. 182–. Springer, 14 June 2017. ISBN 978-3-319-52210-4 Teoksen verkkoversio.
Climacteric Medicine - Where Do We Go?: Proceedings of the 4th Workshop of the International Menopause Society, s. 126–. CRC Press, 22 September 2004. ISBN 978-0-203-02496-6 Teoksen verkkoversio.
Pharmacology for Women's Health, s. 371–. Jones & Bartlett Learning, 25 October 2010. ISBN 978-0-7637-5329-0 Teoksen verkkoversio.
Clinical Gynecologic Endocrinology and Infertility, s. 769–. Lippincott Williams & Wilkins, 28 March 2012. ISBN 978-1-4511-4847-3 Teoksen verkkoversio.

doi.org (Global: 2^nd place; Finnish: 10^th place)

dx.doi.org

Kuhl H: Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, August 2005, 8. vsk, nro Suppl 1, s. 3–63. PubMed:16112947 doi:10.1080/13697130500148875 S2CID:24616324
Escande A, Servant N, Rabenoelina F, Auzou G, Kloosterboer H, Cavaillès V, Balaguer P, Maudelonde T: Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites. The Journal of Steroid Biochemistry and Molecular Biology, 2009, 116. vsk, nro 1–2, s. 8–14. PubMed:19464167 doi:10.1016/j.jsbmb.2009.03.008 S2CID:18346113 Artikkelin verkkoversio.
de Vries CS, Bromley SE, Thomas H, Farmer RD: Tibolone and endometrial cancer: a cohort and nested case-control study in the UK. Drug Safety, 2005, 28. vsk, nro 3, s. 241–249. PubMed:15733028 doi:10.2165/00002018-200528030-00005 S2CID:19872216
Al Kadri H, Hassan S, Al-Fozan HM, Hajeer A: Hormone therapy for endometriosis and surgical menopause. The Cochrane Database of Systematic Reviews, 2009, nro 1, s. CD005997. PubMed:19160262 doi:10.1002/14651858.CD005997.pub2
Lazovic G, Radivojevic U, Marinkovic J: Tibolone: the way to beat many a postmenopausal ailments. Expert Opinion on Pharmacotherapy, 2008, 9. vsk, nro 6, s. 1039–1047. PubMed:18377345 doi:10.1517/14656566.9.6.1039 S2CID:31195615
Garefalakis M, Hickey M: Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence. Clinical Interventions in Aging, 2008, 3. vsk, nro 1, s. 1–8. PubMed:18488873 PubMed Central:2544356 doi:10.2147/CIA.S1043
Ziaei S, Moghasemi M, Faghihzadeh S: Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women. Climacteric, 2010, 13. vsk, nro 2, s. 147–156. PubMed:19731119 doi:10.1080/13697130903009195
Kenemans P, Speroff L: Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas, 2005, 51. vsk, nro 1, s. 21–28. PubMed:15883105 doi:10.1016/j.maturitas.2005.02.011
Davis SR: The effects of tibolone on mood and libido. Menopause, 2002, 9. vsk, nro 3, s. 162–170. PubMed:11973439 doi:10.1097/00042192-200205000-00004 S2CID:11724490
Mocellin S, Pilati P, Briarava M, Nitti D: Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. Journal of the National Cancer Institute, 2016, 108. vsk, nro 2. PubMed:26582062 doi:10.1093/jnci/djv318
Erel CT, Senturk LM, Kaleli S: Tibolone and breast cancer. Postgraduate Medical Journal, 2006, 82. vsk, nro 972, s. 658–662. PubMed:17068276 PubMed Central:2653908 doi:10.1136/pgmj.2005.037184
Wang PH, Cheng MH, Chao HT, Chao KC: Effects of tibolone on the breast of postmenopausal women. Taiwanese Journal of Obstetrics & Gynecology, 2007, 46. vsk, nro 2, s. 121–126. PubMed:17638619 doi:10.1016/S1028-4559(07)60005-9

drugs.com (Global: 399^th place; Finnish: 2,670^th place)

Tibolone International Drugs.com.

duodecimlehti.fi (Global: low place; Finnish: 109^th place)

Pauliina Tuomikoski ja Heli Lyytinen: Näin hoidan vaihdevuosioireita Lääketieteellinen Aikakauskirja Duodecim 2015;131(16):1515-21.

inserm.fr (Global: 9,568^th place; Finnish: low place)

hal.inserm.fr

Escande A, Servant N, Rabenoelina F, Auzou G, Kloosterboer H, Cavaillès V, Balaguer P, Maudelonde T: Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites. The Journal of Steroid Biochemistry and Molecular Biology, 2009, 116. vsk, nro 1–2, s. 8–14. PubMed:19464167 doi:10.1016/j.jsbmb.2009.03.008 S2CID:18346113 Artikkelin verkkoversio.

nih.gov (Global: 4^th place; Finnish: 12^th place)

pubmed.ncbi.nlm.nih.gov

Kuhl H: Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, August 2005, 8. vsk, nro Suppl 1, s. 3–63. PubMed:16112947 doi:10.1080/13697130500148875 S2CID:24616324
Escande A, Servant N, Rabenoelina F, Auzou G, Kloosterboer H, Cavaillès V, Balaguer P, Maudelonde T: Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites. The Journal of Steroid Biochemistry and Molecular Biology, 2009, 116. vsk, nro 1–2, s. 8–14. PubMed:19464167 doi:10.1016/j.jsbmb.2009.03.008 S2CID:18346113 Artikkelin verkkoversio.
de Vries CS, Bromley SE, Thomas H, Farmer RD: Tibolone and endometrial cancer: a cohort and nested case-control study in the UK. Drug Safety, 2005, 28. vsk, nro 3, s. 241–249. PubMed:15733028 doi:10.2165/00002018-200528030-00005 S2CID:19872216
Al Kadri H, Hassan S, Al-Fozan HM, Hajeer A: Hormone therapy for endometriosis and surgical menopause. The Cochrane Database of Systematic Reviews, 2009, nro 1, s. CD005997. PubMed:19160262 doi:10.1002/14651858.CD005997.pub2
Lazovic G, Radivojevic U, Marinkovic J: Tibolone: the way to beat many a postmenopausal ailments. Expert Opinion on Pharmacotherapy, 2008, 9. vsk, nro 6, s. 1039–1047. PubMed:18377345 doi:10.1517/14656566.9.6.1039 S2CID:31195615
Garefalakis M, Hickey M: Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence. Clinical Interventions in Aging, 2008, 3. vsk, nro 1, s. 1–8. PubMed:18488873 PubMed Central:2544356 doi:10.2147/CIA.S1043
Vavilis D, Zafrakas M, Goulis DG, Pantazis K, Agorastos T, Bontis JN: Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists. European Journal of Gynaecological Oncology, 2009, 30. vsk, nro 1, s. 82–84. PubMed:19317264
Ziaei S, Moghasemi M, Faghihzadeh S: Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women. Climacteric, 2010, 13. vsk, nro 2, s. 147–156. PubMed:19731119 doi:10.1080/13697130903009195
Kenemans P, Speroff L: Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas, 2005, 51. vsk, nro 1, s. 21–28. PubMed:15883105 doi:10.1016/j.maturitas.2005.02.011
Davis SR: The effects of tibolone on mood and libido. Menopause, 2002, 9. vsk, nro 3, s. 162–170. PubMed:11973439 doi:10.1097/00042192-200205000-00004 S2CID:11724490
Mocellin S, Pilati P, Briarava M, Nitti D: Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. Journal of the National Cancer Institute, 2016, 108. vsk, nro 2. PubMed:26582062 doi:10.1093/jnci/djv318
Erel CT, Senturk LM, Kaleli S: Tibolone and breast cancer. Postgraduate Medical Journal, 2006, 82. vsk, nro 972, s. 658–662. PubMed:17068276 PubMed Central:2653908 doi:10.1136/pgmj.2005.037184
Wang PH, Cheng MH, Chao HT, Chao KC: Effects of tibolone on the breast of postmenopausal women. Taiwanese Journal of Obstetrics & Gynecology, 2007, 46. vsk, nro 2, s. 121–126. PubMed:17638619 doi:10.1016/S1028-4559(07)60005-9

ncbi.nlm.nih.gov

Garefalakis M, Hickey M: Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence. Clinical Interventions in Aging, 2008, 3. vsk, nro 1, s. 1–8. PubMed:18488873 PubMed Central:2544356 doi:10.2147/CIA.S1043
Erel CT, Senturk LM, Kaleli S: Tibolone and breast cancer. Postgraduate Medical Journal, 2006, 82. vsk, nro 972, s. 658–662. PubMed:17068276 PubMed Central:2653908 doi:10.1136/pgmj.2005.037184

semanticscholar.org (Global: 11^th place; Finnish: 2,329^th place)

api.semanticscholar.org

Kuhl H: Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, August 2005, 8. vsk, nro Suppl 1, s. 3–63. PubMed:16112947 doi:10.1080/13697130500148875 S2CID:24616324
Escande A, Servant N, Rabenoelina F, Auzou G, Kloosterboer H, Cavaillès V, Balaguer P, Maudelonde T: Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites. The Journal of Steroid Biochemistry and Molecular Biology, 2009, 116. vsk, nro 1–2, s. 8–14. PubMed:19464167 doi:10.1016/j.jsbmb.2009.03.008 S2CID:18346113 Artikkelin verkkoversio.
de Vries CS, Bromley SE, Thomas H, Farmer RD: Tibolone and endometrial cancer: a cohort and nested case-control study in the UK. Drug Safety, 2005, 28. vsk, nro 3, s. 241–249. PubMed:15733028 doi:10.2165/00002018-200528030-00005 S2CID:19872216
Lazovic G, Radivojevic U, Marinkovic J: Tibolone: the way to beat many a postmenopausal ailments. Expert Opinion on Pharmacotherapy, 2008, 9. vsk, nro 6, s. 1039–1047. PubMed:18377345 doi:10.1517/14656566.9.6.1039 S2CID:31195615
Davis SR: The effects of tibolone on mood and libido. Menopause, 2002, 9. vsk, nro 3, s. 162–170. PubMed:11973439 doi:10.1097/00042192-200205000-00004 S2CID:11724490

springer.com (Global: 274^th place; Finnish: 418^th place)

adisinsight.springer.com

Tibolone AdisInsight.

Tiboloni (Finnish Wikipedia)

archive.org (Global: 6th place; Finnish: 164th place)

books.google.com (Global: 3rd place; Finnish: 75th place)

doi.org (Global: 2nd place; Finnish: 10th place)